This Research Topic is one volume within the series "The Future of Checkpoint Immunotherapy: New Roads Ahead". Please see the ...

The timing of myocarditis onset during immunotherapy treatment for cancer may predict how likely a person is to die of the condition, according to retrospective study results.Patients who developed my ...

Time-of-day immunotherapy may represent a modifiable factor in cancer care, with earlier immune checkpoint inhibitor ...

Subcutaneous immunotherapy injections for cancer, such as immune checkpoint inhibitors, are an emerging therapy that may replace some traditional intravenous infusions. Common side effects include ...

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that help it ...

Dr. Luc Morris, a surgeon and research lab director at MSK, was the co-senior author of a research study to predict who will benefit from immune checkpoint inhibitors, a type of immunotherapy, using ...

Cancer treatment during the last 40 years depended on three main methods which included surgical procedures and chemotherapy ...

A meta-analysis of 29 studies found that earlier administration of immune checkpoint inhibitors was associated with longer overall and progression-free survival in advanced solid tumors. Benefits were ...

Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...

Immune checkpoint inhibitors, popularized by Allison and Honjo’s Nobel Prize, were one of the first cancer immunotherapies that gained FDA approval. In the 1990s, Allison and Honjo identified the ...

Baseline stool metagenomic profiling in CheckMate 915 linked specific bacterial taxa with recurrence-free survival after ...